AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
SandboxAQ’s Claude Integration Shows AI Drug Discovery Is Trying to Escape the Lab
SandboxAQ is bringing its drug discovery models into Claude, aiming to make advanced molecular design more accessible to users without specialized programming expertise. The move hints at a broader shift from elite, research-only platforms toward more usable AI interfaces for scientific work.
AI Designs Are Reaching the Lab Bench, Not Just the Leaderboard
Drug-target AI is moving from benchmark competitions into preclinical testing, a sign the field is maturing beyond paper claims. The crucial question now is whether these designs can survive the harsher reality of experimental biology.
Why Protein Flexibility Is Emerging as the Next Frontier in AI Drug Design
A new AI platform that models protein flexibility highlights a key limitation in current drug discovery workflows: many models still treat proteins too rigidly. Better representation of structural movement could improve the fidelity of computational design and reduce late-stage failure.
Latent-Y’s Autonomous Drug-Design Agent Shows How Fast the Industry Is Moving Toward Full-Loop Systems
Business Wire’s announcement of Latent-Y as an autonomous AI agent for large-scale drug design adds to a growing wave of systems that aim to run more of the discovery loop with minimal human intervention. The launch is notable not because autonomy is new rhetoric, but because multiple companies are now converging on the same product form: AI as an active research operator rather than a passive prediction engine.
Two AI Drug-Design Startups Show the Field Is Competing on Toolchains, Not Just Models
A FirstWord Pharma look at two AI startups’ internal tooling highlights a maturing competitive landscape in which platform differentiation increasingly comes from integrated toolchains rather than single breakthrough models. For pharma buyers and investors, that is a useful signal that discovery AI is becoming an engineering discipline as much as a scientific one.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.